Main Industry
Health Care
Main Product/Service
EliteCell’s product portfolio includes the “EliteGro™” human‑platelet‑lysate (hPL) line—animal‑serum‑free and xenogeneic‑free cell‑culture supplements for research and commercial cell‑expansion applications; the “EL837” serum‑free lymphocyte culture mediu
Founded Year
2017
Unified Business No.
55627837
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,354,480 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Biomedical EliteCell Corp. focuses on providing safe and effective cell‑culture products for the cell‑therapy industry and research community. With over a decade of cGMP manufacturing experience in the cell supplement market, the company collaborates with
